Search alternatives:
significantly linked » significantly longer (Expand Search), significantly altered (Expand Search), significantly higher (Expand Search)
linked decrease » marked decrease (Expand Search), linear decrease (Expand Search)
teer decrease » greater decrease (Expand Search)
significantly linked » significantly longer (Expand Search), significantly altered (Expand Search), significantly higher (Expand Search)
linked decrease » marked decrease (Expand Search), linear decrease (Expand Search)
teer decrease » greater decrease (Expand Search)
-
181
-
182
-
183
-
184
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: -
185
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
186
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
Published 2025Subjects: -
187
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: -
188
-
189
-
190
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: -
191
-
192
-
193
-
194
-
195
-
196
-
197
B2 decreases glycolytic intermediates in cells.
Published 2025“…Other abbreviations: HGA, DL-hydroxyglutaric acid; PEP, phosphoenolpyruvic acid; 3-PGA, 3-phosphoglyceric acid; G3P; glyceraldehyde 3-phosphate; Data (n = 5) are shown as mean±SD. Not significant (ns): **<i>P</i> ≤ 0.01, ****<i>P</i> ≤ 0.0001by one-way ANOVA with multiple comparison of the mean of each test group to the mean of the vehicle control. …”
-
198
-
199
Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration.
Published 2025“…<p><b>(A)</b> A significant decrease in the proliferative clonal capacity of U87MG colonies was observed with 70ΜM and 100ΜM SHG-44 treatment. …”
-
200